Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Down 45.7% in May

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totaling 2,031,410 shares, a drop of 45.7% from the April 30th total of 3,744,107 shares. Based on an average daily volume of 3,636 shares, the days-to-cover ratio is currently 558.7 days.

Genomma Lab Internacional Price Performance

Shares of GNMLF opened at $1.08 on Monday. The business’s 50-day moving average price is $1.04 and its 200 day moving average price is $1.02. Genomma Lab Internacional has a 1-year low of $0.91 and a 1-year high of $1.27.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.